[Partusisten in obstetrics].
Thanks to a tocolytic agent we are no longer helpless against the premature onset of labour. We have achieved very good therapeutic results with the tocolytic agent Th 1165 a (Partusisten). No harmful effects have been observed in mother or child during short- or long-term treatment with Partusisten. Betasympathomimetics are today one of the most important groups of drugs in use in the delivery room. The therapeutic results were considered satisfactory in 152 pregnant women.
D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009921:Metaproterenol / Q000009:adverse effects / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010636:Phenols / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D013610:Tachycardia / Q000139:chemically induced / Q000517:prevention & control; D014700:Verapamil / Q000627:therapeutic use
D010636:Phenols; D009921:Metaproterenol; D014700:Verapamil
Partusisten in der Geburtshilfe